OncoTherapy Science, Inc. (TYO:4564)
Japan flag Japan · Delayed Price · Currency is JPY
21.00
0.00 (0.00%)
Aug 27, 2026, 1:50 PM JST

OncoTherapy Science Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-908-813-1,285-1,116-2,570
Depreciation & Amortization
----16
Loss (Gain) From Sale of Assets
63-15421547
Other Operating Activities
-3-2-2-17-3
Change in Accounts Receivable
-4-6387276-247
Change in Inventory
16-425131-189
Change in Accounts Payable
-2021-158-240385
Change in Other Net Operating Assets
-6646-48151-12
Operating Cash Flow
-922-815-1,227-794-2,073
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-62--2-4-456
Other Investing Activities
-1--31-16-11
Investing Cash Flow
-63--33-20-467

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Issuance of Common Stock
2,2921,178676-1,478
Repurchase of Common Stock
--1---
Other Financing Activities
-51-56-595-
Financing Cash Flow
2,2411,121671951,478

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-1----
Net Cash Flow
1,255306-589-719-1,062

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-984-815-1,229-798-2,529
Free Cash Flow Growth
-----
Free Cash Flow Margin
-121.78%-108.67%-201.47%-70.37%-219.34%
Free Cash Flow Per Share
-3.00-3.12-5.78-4.14-13.49
Levered Free Cash Flow
-674.88-512.75-937-231.88-1,782
Unlevered Free Cash Flow
-674.25-512.13-937-231.88-1,782

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
11---
Cash Income Tax Paid
22222
Change in Working Capital
-74--94318-63